NFE2L2 and hepatocellular carcinoma: Of note, persistent phosphorylation of p62 has been reported in hepatic adenoma of liver-specific autophagy-deficient mice [215] as well as in human HCC positive for hepatitis C, where it was found to promote metabolic reprogramming by increased NRF2 activation [216].